| Product Code: ETC10557010 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Japan continued to heavily rely on imports of disease modifying agents, with top exporters being the USA, Spain, Metropolitan France, Belgium, and Italy. High Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a modest compound annual growth rate (CAGR) of 0.74% from 2020 to 2024, the impressive growth rate of 28.07% from 2023 to 2024 suggests a potential surge in demand for these products in the Japanese market. This trend highlights the importance of international trade in ensuring a stable supply of disease modifying agents for Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Disease Modifying Agents Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Disease Modifying Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Disease Modifying Agents Market - Industry Life Cycle |
3.4 Japan Disease Modifying Agents Market - Porter's Five Forces |
3.5 Japan Disease Modifying Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Disease Modifying Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Disease Modifying Agents Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Japan Disease Modifying Agents Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.9 Japan Disease Modifying Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Disease Modifying Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Japan |
4.2.2 Rising healthcare expenditure and government funding for disease management |
4.2.3 Technological advancements in disease-modifying agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for new disease-modifying agents |
4.3.2 High cost associated with disease-modifying agents |
4.3.3 Lack of awareness and education about disease-modifying agents among patients and healthcare providers |
5 Japan Disease Modifying Agents Market Trends |
6 Japan Disease Modifying Agents Market, By Types |
6.1 Japan Disease Modifying Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Disease Modifying Agents Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Japan Disease Modifying Agents Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 Japan Disease Modifying Agents Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 Japan Disease Modifying Agents Market Revenues & Volume, By Gene Therapies, 2021 - 2031F |
6.2 Japan Disease Modifying Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Disease Modifying Agents Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.2.3 Japan Disease Modifying Agents Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.4 Japan Disease Modifying Agents Market Revenues & Volume, By Genetic Diseases, 2021 - 2031F |
6.3 Japan Disease Modifying Agents Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Japan Disease Modifying Agents Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.3.3 Japan Disease Modifying Agents Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.4 Japan Disease Modifying Agents Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.4 Japan Disease Modifying Agents Market, By Form |
6.4.1 Overview and Analysis |
6.4.2 Japan Disease Modifying Agents Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.3 Japan Disease Modifying Agents Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.4.4 Japan Disease Modifying Agents Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5 Japan Disease Modifying Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Disease Modifying Agents Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 Japan Disease Modifying Agents Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 Japan Disease Modifying Agents Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 Japan Disease Modifying Agents Market Import-Export Trade Statistics |
7.1 Japan Disease Modifying Agents Market Export to Major Countries |
7.2 Japan Disease Modifying Agents Market Imports from Major Countries |
8 Japan Disease Modifying Agents Market Key Performance Indicators |
8.1 Number of clinical trials for disease-modifying agents in Japan |
8.2 Adoption rate of disease-modifying agents by healthcare facilities |
8.3 Patient adherence rate to disease-modifying agent treatment plans |
9 Japan Disease Modifying Agents Market - Opportunity Assessment |
9.1 Japan Disease Modifying Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Disease Modifying Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Disease Modifying Agents Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Japan Disease Modifying Agents Market Opportunity Assessment, By Form, 2021 & 2031F |
9.5 Japan Disease Modifying Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Disease Modifying Agents Market - Competitive Landscape |
10.1 Japan Disease Modifying Agents Market Revenue Share, By Companies, 2024 |
10.2 Japan Disease Modifying Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here